Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product... including commentary by Symmons DPM.

Bibliographic Details
Published in:Lancet Vol. 348; no. 9039; pp. 1413 - 1419
Main Authors: Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S
Format: commentary research tables/charts Journal Article
Published: Lancet 11/23/1996
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107278167&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107278167
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 11/23/1996
      vid: 348
      iid: 9039
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        107278167
        107278167
        1998048507
        10.1016/s0140-6736(96)01254-8
        NLM8937281
        107278167
      ppf: 1413
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: T
      tig:
        atl: Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product... including commentary by Symmons DPM.
      aug:
        au:
          Kelly JP
          Kaufman DW
          Jurgelon JM
          Sheehan J
          Koff RS
          Shapiro S
        affil: Slone Epidemiology Unit, School of Public Health, Boston University School of Medicine, Brookline, Massachusetts 02146
      sug:
        subj:
          Antiinflammatory Agents, Non-Steroidal Adverse Effects
          Gastrointestinal Hemorrhage Chemically Induced
          Aspirin Adverse Effects
          Case Control Studies
          Endoscopy, Gastrointestinal
          Tablets
          Buffers
          Aspirin Administration and Dosage
          Antiinflammatory Agents, Non-Steroidal Administration and Dosage
          Middle Age
          Adult
          Aged
          Adolescence
          Interviews
          Questionnaires
          Confidence Intervals
          Funding Source
          Relative Risk
          Logistic Regression
          Human
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Aged: 65+ years
          Adolescent: 13-18 years
      pubtype: Academic Journal
      doctype:
        commentary
        research
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N